{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:49:55Z","timestamp":1789267795282,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,9,26]],"date-time":"2011-09-26T00:00:00Z","timestamp":1316995200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Increased serum levels of homocysteine and uric acid have each been associated with cardiovascular risk. We analyzed whether homocysteine and uric acid were associated with glomerular filtration rate (GFR) and albuminuria independently of each other. We also investigated the association of <jats:italic>MTHFR<\/jats:italic> polymorphisms related to homocysteine with albuminuria to get further insight into causality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This was a cross-sectional population-based study in Caucasians (<jats:italic>n<\/jats:italic> = 5913). Hyperhomocysteinemia was defined as total serum homocysteine \u2265 15 \u03bcmol\/L. Albuminuria was defined as urinary albumin-to-creatinine ratio &gt; 30 mg\/g.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Uric acid was associated positively with homocysteine (r = 0.246 in men and r = 0.287 in women, <jats:italic>P<\/jats:italic> &lt; 0.001). The prevalence of albuminuria increased across increasing homocysteine categories (from 6.4% to 17.3% in subjects with normal GFR and from 3.5% to 14.5% in those with reduced GFR, <jats:italic>P<\/jats:italic> for trend &lt; 0.005). Hyperhomocysteinemia (OR = 2.22, 95% confidence interval: 1.60-3.08, <jats:italic>P<\/jats:italic> &lt; 0.001) and elevated serum uric acid (OR = 1.27, 1.08-1.50, per 100 \u03bcmol\/L, <jats:italic>P<\/jats:italic> = 0.004) were significantly associated with albuminuria, independently of hypertension and type 2 diabetes. The 2-fold higher risk of albuminuria associated with hyperhomocysteinemia was similar to the risk associated with hypertension or diabetes. <jats:italic>MTHFR<\/jats:italic> alleles related to higher homocysteine were associated with increased risk of albuminuria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>In the general adult population, elevated serum homocysteine and uric acid were associated with albuminuria independently of each other and of renal function.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2458-11-733","type":"journal-article","created":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T06:47:15Z","timestamp":1317106035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study"],"prefix":"10.1186","volume":"11","author":[{"given":"Franziska","family":"Marti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vollenweider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro-Manuel","family":"Marques-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Mooser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Waeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Paccaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murielle","family":"Bochud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,9,26]]},"reference":[{"key":"3499_CR1","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1523-1755.2004.00732.x","volume":"66","author":"ME Francis","year":"2004","unstructured":"Francis ME, Eggers PW, Hostetter TH, Briggs JP: Association between serum homocysteine and markers of impaired kidney function in adults in the United States.[see comment]. Kidney International. 2004, 66: 303-312. 10.1111\/j.1523-1755.2004.00732.x.","journal-title":"Kidney International"},{"key":"3499_CR2","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1161\/01.CIR.101.13.1506","volume":"101","author":"EK Hoogeveen","year":"2000","unstructured":"Hoogeveen EK, Kostense PJ, Jakobs C, Dekker JM, Nijpels G, Heine RJ, et al: Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes: 5-year follow-up of the Hoorn Study. Circulation. 2000, 101: 1506-1511.","journal-title":"Circulation"},{"key":"3499_CR3","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.4065\/83.11.1203","volume":"83","author":"LL Humphrey","year":"2008","unstructured":"Humphrey LL, Fu R, Rogers K, Freeman M, Helfand M: Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis. Mayo Clin Proc. 2008, 83: 1203-1212. 10.4065\/83.11.1203.","journal-title":"Mayo Clin Proc"},{"key":"3499_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1681\/ASN.2004070576","volume":"16","author":"WC Winkelmayer","year":"2005","unstructured":"Winkelmayer WC, Kramar R, Curhan GC, Chandraker A, Endler G, Fodinger M, et al: Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study. J Am Soc Nephrol. 2005, 16: 255-260.","journal-title":"J Am Soc Nephrol"},{"key":"3499_CR5","doi-asserted-by":"crossref","first-page":"1731S","DOI":"10.1093\/jn\/136.6.1731S","volume":"136","author":"H Refsum","year":"2006","unstructured":"Refsum H, Nurk E, Smith AD, Ueland PM, Gjesdal CG, Bjelland I, et al: The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr. 2006, 136: 1731S-1740S.","journal-title":"J Nutr"},{"key":"3499_CR6","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/01.HYP.0000102971.85504.7c","volume":"42","author":"MJ Sarnak","year":"2003","unstructured":"Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003, 42: 1050-1065. 10.1161\/01.HYP.0000102971.85504.7c.","journal-title":"Hypertension"},{"key":"3499_CR7","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998, 32: S112-S119. 10.1053\/ajkd.1998.v32.pm9820470.","journal-title":"Am J Kidney Dis"},{"key":"3499_CR8","doi-asserted-by":"publisher","first-page":"17012","DOI":"10.1074\/jbc.272.27.17012","volume":"272","author":"GR Upchurch Jr","year":"1997","unstructured":"Upchurch GR, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF, et al: Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem. 1997, 272: 17012-17017. 10.1074\/jbc.272.27.17012.","journal-title":"J Biol Chem"},{"key":"3499_CR9","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","volume":"338","author":"GN Welch","year":"1998","unstructured":"Welch GN, Loscalzo J: Homocysteine and atherothrombosis. N Engl J Med. 1998, 338: 1042-1050. 10.1056\/NEJM199804093381507.","journal-title":"N Engl J Med"},{"key":"3499_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/sj.ki.4495353","volume":"54","author":"EK Hoogeveen","year":"1998","unstructured":"Hoogeveen EK, Kostense PJ, Jager A, Heine RJ, Jakobs C, Bouter LM, et al: Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int. 1998, 54: 203-209. 10.1038\/sj.ki.4495353.","journal-title":"Kidney Int"},{"key":"3499_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/01.ATV.21.1.74","volume":"21","author":"A Jager","year":"2001","unstructured":"Jager A, Kostense PJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, et al: Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study. Arterioscler Thromb Vasc Biol. 2001, 21: 74-81. 10.1161\/01.ATV.21.1.74.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3499_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1007\/s001250050969","volume":"41","author":"A Chico","year":"1998","unstructured":"Chico A, Perez A, Cordoba A, Arcelus R, Carreras G, de LA, et al: Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?. Diabetologia. 1998, 41: 684-693. 10.1007\/s001250050969.","journal-title":"Diabetologia"},{"key":"3499_CR13","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/S0026-0495(98)90344-4","volume":"47","author":"M Lanfredini","year":"1998","unstructured":"Lanfredini M, Fiorina P, Peca MG, Veronelli A, Mello A, Astorri E, et al: Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients. Metabolism. 1998, 47: 915-921. 10.1016\/S0026-0495(98)90344-4.","journal-title":"Metabolism"},{"key":"3499_CR14","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/S0272-6386(99)70442-7","volume":"33","author":"WF Keane","year":"1999","unstructured":"Keane WF, Eknoyan G: Proteinuria, albuminuria, risk, assessment, detection, elimination (PARADE): a position paper of the National Kidney Foundation. Am J Kidney Dis. 1999, 33: 1004-1010. 10.1016\/S0272-6386(99)70442-7.","journal-title":"Am J Kidney Dis"},{"key":"3499_CR15","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/S0140-6736(82)92450-3","volume":"1","author":"GC Viberti","year":"1982","unstructured":"Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982, 1: 1430-1432.","journal-title":"Lancet"},{"key":"3499_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/ije\/dyh008","volume":"33","author":"MF Yuyun","year":"2004","unstructured":"Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, et al: Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol. 2004, 33: 189-198. 10.1093\/ije\/dyh008.","journal-title":"Int J Epidemiol"},{"key":"3499_CR17","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1681\/ASN.2008010080","volume":"19","author":"RP Obermayr","year":"2008","unstructured":"Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R: Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol. 2008, 19: 2407-2413. 10.1681\/ASN.2008010080.","journal-title":"J Am Soc Nephrol"},{"key":"3499_CR18","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1053\/j.ajkd.2008.12.021","volume":"53","author":"M Madero","year":"2009","unstructured":"Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek JW, et al: Uric acid and long-term outcomes in CKD. Am J Kidney Dis. 2009, 53: 796-803. 10.1053\/j.ajkd.2008.12.021.","journal-title":"Am J Kidney Dis"},{"key":"3499_CR19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ajcn\/64.4.587","volume":"64","author":"S Lussier-Cacan","year":"1996","unstructured":"Lussier-Cacan S, Xhignesse M, Piolot A, Selhub J, Davignon J, Genest J: Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr. 1996, 64: 587-593.","journal-title":"Am J Clin Nutr"},{"key":"3499_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0021-9150(94)05481-W","volume":"114","author":"MR Malinow","year":"1995","unstructured":"Malinow MR, Levenson J, Giral P, Nieto FJ, Razavian M, Segond P, et al: Role of blood pressure, uric acid, and hemorheological parameters on plasma homocyst(e)ine concentration. Atherosclerosis. 1995, 114: 175-183. 10.1016\/0021-9150(94)05481-W.","journal-title":"Atherosclerosis"},{"key":"3499_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000142725","volume":"31","author":"JT Kielstein","year":"2008","unstructured":"Kielstein JT, Salpeter SR, Buckley NS, Cooke JP, Fliser D: Two cardiovascular risk factors in one? Homocysteine and its relation to glomerular filtration rate. A meta-analysis of 41 studies with 27,000 participants. Kidney Blood Press Res. 2008, 31: 259-267. 10.1159\/000142725.","journal-title":"Kidney Blood Press Res"},{"key":"3499_CR22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2261-8-6","volume":"8","author":"M Firmann","year":"2008","unstructured":"Firmann M, Mayor V, Vidal PM, Bochud M, Pecoud A, Hayoz D, et al: The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord. 2008, 8: 6-10.1186\/1471-2261-8-6.","journal-title":"BMC Cardiovasc Disord"},{"key":"3499_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00126097-200208000-00006","volume":"7","author":"MA El Assaad","year":"2002","unstructured":"El Assaad MA, Topouchian JA, Darne BM, Asmar RG: Validation of the Omron HEM-907 device for blood pressure measurement. Blood Press Monit. 2002, 7: 237-241. 10.1097\/00126097-200208000-00006.","journal-title":"Blood Press Monit"},{"key":"3499_CR24","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1161\/CIRCULATIONAHA.106.177321","volume":"114","author":"FC Brosius","year":"2006","unstructured":"Brosius FC, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, et al: Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation. 2006, 114: 1083-1087. 10.1161\/CIRCULATIONAHA.106.177321.","journal-title":"Circulation"},{"key":"3499_CR25","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al: National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003, 139: 137-147.","journal-title":"Ann Intern Med"},{"key":"3499_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16: 31-41. 10.1159\/000180580.","journal-title":"Nephron"},{"key":"3499_CR27","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995, 10: 111-113. 10.1038\/ng0595-111.","journal-title":"Nat Genet"},{"key":"3499_CR28","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1038\/ng.140","volume":"40","author":"RJ Loos","year":"2008","unstructured":"Loos RJ, Lindgren CM, Li S, Wheeler E, Zhao JH, Prokopenko I, et al: Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet. 2008, 40: 768-775. 10.1038\/ng.140.","journal-title":"Nat Genet"},{"key":"3499_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0140-6736(05)70152-5","volume":"365","author":"JP Casas","year":"2005","unstructured":"Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD: Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet. 2005, 365: 224-232.","journal-title":"Lancet"},{"key":"3499_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1053\/j.ajkd.2008.12.023","volume":"53","author":"RL Jamison","year":"2009","unstructured":"Jamison RL, Shih MC, Humphries DE, Guarino PD, Kaufman JS, Goldfarb DS, et al: Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study. Am J Kidney Dis. 2009, 53: 779-789. 10.1053\/j.ajkd.2008.12.023.","journal-title":"Am J Kidney Dis"},{"key":"3499_CR31","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"DS Wald","year":"2002","unstructured":"Wald DS, Law M, Morris JK: Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ. 2002, 325: 1202-10.1136\/bmj.325.7374.1202.","journal-title":"BMJ"},{"key":"3499_CR32","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1034\/j.1600-0412.2001.080009803.x","volume":"80","author":"FF Lauszus","year":"2001","unstructured":"Lauszus FF, Gron PL, Klebe JG: Association of polymorphism of methylene-tetrahydro-folate-reductase with urinary albumin excretion rate in type 1 diabetes mellitus but not with preeclampsia, retinopathy, and preterm delivery. Acta Obstet Gynecol Scand. 2001, 80: 803-806. 10.1034\/j.1600-0412.2001.080009803.x.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"3499_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.diabres.2006.05.018","volume":"75","author":"N Mtiraoui","year":"2007","unstructured":"Mtiraoui N, Ezzidi I, Chaieb M, Marmouche H, Aouni Z, Chaieb A, et al: MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract. 2007, 75: 99-106. 10.1016\/j.diabres.2006.05.018.","journal-title":"Diabetes Res Clin Pract"},{"key":"3499_CR34","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/S0140-6736(05)79188-1","volume":"352","author":"S Neugebauer","year":"1998","unstructured":"Neugebauer S, Baba T, Watanabe T: Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients. Lancet. 1998, 352: 454-","journal-title":"Lancet"},{"key":"3499_CR35","doi-asserted-by":"publisher","first-page":"260","DOI":"10.2337\/diacare.23.2.260b","volume":"23","author":"E Noiri","year":"2000","unstructured":"Noiri E, Taguchi J, Nakao A, Fujita T: MTHFR gene polymorphism as an exacerbation factor of diabetic nephropathy in type 2 diabetes. Analysis in Japanese male hemodialysis patients. Diabetes Care. 2000, 23: 260-","journal-title":"Diabetes Care"},{"key":"3499_CR36","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.diabres.2003.10.022","volume":"64","author":"J Sun","year":"2004","unstructured":"Sun J, Xu Y, Zhu Y, Lu H: Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract. 2004, 64: 185-190. 10.1016\/j.diabres.2003.10.022.","journal-title":"Diabetes Res Clin Pract"},{"key":"3499_CR37","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/ndt\/gfl512","volume":"22","author":"CA Boger","year":"2007","unstructured":"Boger CA, Stubanus M, Haak T, Gotz AK, Christ J, Hoffmann U, et al: Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy. Nephrol Dial Transplant. 2007, 22: 154-162.","journal-title":"Nephrol Dial Transplant"},{"key":"3499_CR38","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1399-5448.2008.00374.x","volume":"9","author":"EJ Wiltshire","year":"2008","unstructured":"Wiltshire EJ, Mohsin F, Chan A, Donaghue KC: Methylenetetrahydrofolate reductase and methionine synthase reductase gene polymorphisms and protection from microvascular complications in adolescents with type 1 diabetes. Pediatr Diabetes. 2008, 9: 348-353. 10.1111\/j.1399-5448.2008.00374.x.","journal-title":"Pediatr Diabetes"},{"key":"3499_CR39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/oxfordjournals.bmb.a072635","volume":"49","author":"L Baud","year":"1993","unstructured":"Baud L, Ardaillou R: Involvement of reactive oxygen species in kidney damage. Br Med Bull. 1993, 49: 621-629.","journal-title":"Br Med Bull"},{"key":"3499_CR40","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0272-6386(04)00813-3","volume":"44","author":"T Ninomiya","year":"2004","unstructured":"Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Tanaka K, Okubo K, et al: Hyperhomocysteinemia and the development of chronic kidney disease in a general population: the Hisayama study. Am J Kidney Dis. 2004, 44: 437-445.","journal-title":"Am J Kidney Dis"},{"key":"3499_CR41","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351: 1296-1305. 10.1056\/NEJMoa041031.","journal-title":"N Engl J Med"},{"key":"3499_CR42","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1053\/euhj.2002.3172","volume":"23","author":"P O'Callaghan","year":"2002","unstructured":"O'Callaghan P, Meleady R, Fitzgerald T, Graham I: Smoking and plasma homocysteine. Eur Heart J. 2002, 23: 1580-1586. 10.1053\/euhj.2002.3172.","journal-title":"Eur Heart J"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-733.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-11-733\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-733","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-733.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T16:56:20Z","timestamp":1630515380000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-11-733"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,26]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["3499"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-11-733","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,26]]},"assertion":[{"value":"15 August 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"733"}}